STOCK TITAN
  1. Home
  2. Sec-filings
  3. VCEL
  4. [ARS] Vericel Corp SEC Filing

[ARS] Vericel Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS

Rhea-AI Filing Summary

Analyzing...
ARS - Vericel Corp

ARS Filing - Vericel Corp

This filing is available as a PDF document.

Filing Type: ARS

Company: Vericel Corp (VCEL)

Acceptance Date: 2026-03-19T07:30:21.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Vericel

NASDAQ:VCEL

View VCEL Stock Overview →

VCEL Rankings

#2330 Ranked by Market Cap
N/A Ranked by Dividends

VCEL Latest News

Mar 4, 2026
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility
Mar 3, 2026
Vericel to Present at Multiple Upcoming Investor Conferences
Feb 26, 2026
Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results
Feb 12, 2026
Vericel to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 26, 2026
Jan 13, 2026
Vericel Announces Preliminary 2025 Financial Results and Business Updates

VCEL Latest SEC Filings

Mar 19, 2026
[DEF 14A] Vericel Corp Definitive Proxy Statement
Mar 4, 2026
[Form 4] Vericel Corp Insider Trading Activity
Mar 4, 2026
[Form 4] Vericel Corp Insider Trading Activity
Mar 2, 2026
[144] Vericel Corp SEC Filing
Mar 2, 2026
[144] Vericel Corp SEC Filing

VCEL Stock Data

1.64B
50.02M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
CAMBRIDGE